MARKET

VKTX

VKTX

Viking Therapeutics Inc
NASDAQ
36.15
-0.93
-2.51%
Closed 19:59 12/15 EST
OPEN
36.77
PREV CLOSE
37.08
HIGH
37.16
LOW
35.95
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
48.55
52 WEEK LOW
18.92
MARKET CAP
4.09B
P/E (TTM)
-17.0664
1D
5D
1M
3M
1Y
5Y
1D
CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval
NASDAQ · 23h ago
Weekly Report: what happened at VKTX last week (1208-1212)?
Weekly Report · 1d ago
Eli Lilly: The Right Long-Term Strategy
Seeking Alpha · 3d ago
Notable Friday Option Activity: WMT, VKTX, DPZ
NASDAQ · 3d ago
Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win
NASDAQ · 3d ago
NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?
NASDAQ · 3d ago
3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026
NASDAQ · 5d ago
Crypto Currents: Bitcoin settlement volume flips Visa
TipRanks · 5d ago
More
About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.

Webull offers Viking Therapeutics Inc stock information, including NASDAQ: VKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTX stock methods without spending real money on the virtual paper trading platform.